EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the level of metabolic reprogramming and the role of prognostic factor SF3A3 in hepatocellular carcinoma through integrated single-cell landscape analysis

Wanshuo Wei, Yuan Gan, Xindan Zhang, Yumo Chen, Zengfeng Huang, Shuhan Wang, Xiaomei Xie, Yongle Li, Pengtao Qin, Lihe Jiang iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0323559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wanshuo Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Scool of Clinical Medicine, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, Guangxi Province, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA Splicing Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant of Guangxi Natural Science Foundation, Research project on high-level talents of Youjiang Medical College for Nationalities, Fujian Provincial Key Laboratory of Innovative Drug Target Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate metabolic reprogramming heterogeneity in hepatocellular carcinoma (HCC) cells and identify novel therapeutic targets for HCC treatment. Single-cell RNA sequencing data from public databases were used to analyze the TME of HCC and reveal the characteristics of different cell subsets, including mononuclear phagocytes, epithelial cells, endothelial cells, NK/T cells, B cells, and unknown cells. The analysis revealed that these cell subsets play their own unique roles in tumor progression and immune escape. Analysis of copy number variations (CNVs) was performed on tumor-derived epithelial cells, with the epithelial cells in Cluster 3 subgroup showing the highest CNV levels. Gene Ontology (GO) enrichment analysis revealed that these cell subsets were involved in a variety of biological processes such as immune response, cell communication, and metabolic pathways, which were consistent with their functional roles. Pseudotemporal analysis further delineated the malignant trajectory of HCC cells, with Cluster 3 exhibiting enhanced phosphatidylinositol metabolism, suggesting a critical role for metabolic reprogramming in tumor invasion and proliferation. Furthermore, a diagnostic model incorporating metabolic reprogramming-associated gene signatures was established, which effectively distinguished HCC from normal tissues. Among these signatures, splicing factor 3a subunit 3 (SF3A3) was identified as both diagnostic and independent prognostic biomarker. Mechanistically, SF3A3 knockdown in HCC cell lines significantly suppressed proliferation, migration, PI3K/AKT signaling, and EMT marker expression, thereby demonstrating its role in driving HCC aggressiveness. In conclusion, these findings elucidate novel molecular characteristics of HCC based on metabolic reprogramming, while establishing SF3A3 as a promising multi-faceted target for HCC diagnosis, prognostic assessment, and therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA Splicing FactorsHumansPrognosisSingle-Cell AnalysisDNA Copy Number VariationsGene Expression Regulation, NeoplasticCell Line, TumorBiomarkers, TumorCell ProliferationMaleMetabolic Reprogramming

Substanzen

RNA Splicing FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Scool of Clinical Medicine, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, Guangxi Province, P.R. China.
  • The First Affiliated Hospital, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi Province, P.R. China.
  • Fujian Key Laboratory of Medical Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, Fujian Province, P.R. China.
  • Key Laboratory of Biomarkers and in Vitro Diagnosis Translation of Zhejiang province, Hangzhou, Zhejiang province, P.R. China.

ORCID-Profile: Lihe Jiang

Förderung

  • Grant of Guangxi Natural Science Foundation
  • Research project on high-level talents of Youjiang Medical College for Nationalities
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research
  • Opening Fund of Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang Province
  • Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province
  • Fujian Key Laboratory of Medical Bioinformatics
  • Guangxi provincial-level project of university students' innovation and entrepreneurship in 2023

Zitieren

APA

Wei, W., Gan, Y., Zhang, X., Chen, Y., Huang, Z., Wang, S., Xie, X., Li, Y., Qin, P., & Jiang, L. (2025). Exploring the level of metabolic reprogramming and the role of prognostic factor SF3A3 in hepatocellular carcinoma through integrated single-cell landscape analysis. PLOS One. https://doi.org/10.1371/journal.pone.0323559

Vancouver

Wei W, Gan Y, Zhang X, Chen Y, Huang Z, Wang S, et al. Exploring the level of metabolic reprogramming and the role of prognostic factor SF3A3 in hepatocellular carcinoma through integrated single-cell landscape analysis. PLOS One. 2025. doi:10.1371/journal.pone.0323559

BibTeX
@article{Wei2025,
  author = {Wei, Wanshuo and Gan, Yuan and Zhang, Xindan and Chen, Yumo and Huang, Zengfeng and Wang, Shuhan and Xie, Xiaomei and Li, Yongle and Qin, Pengtao and Jiang, Lihe},
  title = {Exploring the level of metabolic reprogramming and the role of prognostic factor SF3A3 in hepatocellular carcinoma through integrated single-cell landscape analysis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0323559}
}
Kostenlos starten →